Ra Capital Management, L.P. - Director, 10%+ Owner at Cytek Biosciences, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director, 10%+ Owner
Stock Symbol
CTKB on Nasdaq
Industry
Laboratory Analytical Instruments
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ra Capital Management, L.P. since 7/7/2023

Holdings reported by Ra Capital Management, L.P. for Cytek Biosciences, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 13,381,054 $127 M $9.50 Mar 15, 2022 Indirect
Series D Preferred Stock 0 Jul 27, 2021 Indirect Common Stock

Transactions reported by Ra Capital Management, L.P. for Cytek Biosciences, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership